ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 61 filers reported holding ADC THERAPEUTICS SA in Q2 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,297 | -15.4% | 22,629 | +102.7% | 0.00% | – |
Q2 2023 | $24,002 | +29.8% | 11,164 | +17.7% | 0.00% | – |
Q1 2023 | $18,490 | -26.0% | 9,482 | +44.0% | 0.00% | – |
Q4 2022 | $25,000 | 0.0% | 6,584 | +25.2% | 0.00% | – |
Q3 2022 | $25,000 | -43.2% | 5,257 | -4.1% | 0.00% | – |
Q2 2022 | $44,000 | -6.4% | 5,483 | +68.8% | 0.00% | – |
Q1 2022 | $47,000 | +840.0% | 3,248 | +1270.5% | 0.00% | – |
Q4 2021 | $5,000 | -44.4% | 237 | -30.7% | 0.00% | – |
Q3 2021 | $9,000 | 0.0% | 342 | -12.8% | 0.00% | – |
Q2 2021 | $9,000 | +80.0% | 392 | +116.6% | 0.00% | – |
Q1 2021 | $5,000 | -16.7% | 181 | 0.0% | 0.00% | – |
Q4 2020 | $6,000 | +20.0% | 181 | +9.7% | 0.00% | – |
Q3 2020 | $5,000 | -37.5% | 165 | -7.8% | 0.00% | – |
Q2 2020 | $8,000 | – | 179 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 1,186,215 | $9,430,000 | 5.29% |
GCM Grosvenor Holdings, LLC | 1,298,012 | $10,319,000 | 2.33% |
Redmile Group, LLC | 7,512,029 | $59,721,000 | 2.28% |
MPM BioImpact LLC | 334,384 | $2,658,000 | 0.74% |
Indie Asset Partners, LLC | 93,989 | $747,000 | 0.66% |
Eventide Asset Management | 1,879,959 | $14,946,000 | 0.32% |
Walleye Capital LLC | 888,700 | $7,065,000 | 0.20% |
Endurant Capital Management LP | 58,967 | $469,000 | 0.16% |
HHLR ADVISORS, LTD. | 500,000 | $3,975,000 | 0.08% |
Matrix Capital Management Company, LP | 400,000 | $3,180,000 | 0.07% |